Log on / register
Feedback | Support | My details
Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.
Miura K, Keister DB, Muratova OV, Sattabongkot J, Long CA, Saul A
Malar J 2007, 6:107
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.
Wu Y, Ellis RD, Shaffer D, Fontes E, Malkin EM, Mahanty S, Fay MP, Narum D, Rausch K, Miles AP, Aebig J, Orcutt A, Muratova O, Song G, Lambert L, Zhu D, Miura K, Long C, Saul A, Miller LH, Durbin AP
PLoS One 2008, 3:e2636
 [PubMed Central] [PubMed] [Related articles]
2.
Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation.
LeBlanc R, Vasquez Y, Hannaman D, Kumar N
Vaccine 2008 Jan 10, 26:185-92
 [PubMed Central] [PubMed] [Related articles]
3.
*** Unable to retrieve article 18612426 ***

 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 2 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.